3 Q&A interview with CEO, Ömer Özkan, MVA-member company, Enbiosis Biotechnology

Oct 1, 2021

Q1: As a microbiome company with offices in the UK, The Netherlands, Turkey and Ukraine, why have you decided to become a member of our Danish-Swedish life science cluster organization?

Prior to Copenhagen Capacity reaching out to us, we had not even considered the possibility of investing in Denmark. We were considering Berlin in Germany and Boston/San-Francisco in the US. However, as we learned more about Greater Copenhagen’s life sciences industry we were very impressed and attracted by a number of factors, such as the access to innovative environment, specific knowledge, competencies, R&D, clusters, partners, and technology. We have also considered factors like the ease of doing business, quality of life, availability of highly-skilled labour and political stability. Since we are a biotechnology company, interested in human microbiome, drug discovery, nutrition and probiotic development, we were also attracted by the opportunity to join the Microbiome network for Medicon Valley Alliance members. Having considered all this information, we decided to establish a branch office in Copenhagen. Copenhagen Capacity has made this decision easy for us, by introducing us to the community, helping us establish a virtual office in Symbion and become a member of Medicon Valley Alliance.

Q2: Where did you learn about Medicon Valley and the microbiome R&D taking place here in the region?

Copenhagen Capacity reached out and contacted us. Thanks to their proactive approach, we found out about Greater Copenhagen’s life sciences industry in general, and Medicon Valley and the microbiome R&D in particular.

Q3: What are you key objectives in Medicon Valley and the Nordics?

Our activity in Denmark is focused on science-based R&D and knowledge-intensive activities. The primary function of our company in Denmark is R&D, Innovation and Design Centre and our goal is to develop new or significantly improved products or services with respect to their capabilities, user friendliness, components, sub-systems or processes. When the project is fully implemented, we expect to have 20 employees onboard within approximately 3 years.

Most recent news